MRVI — MARAVAI LIFESCIENCES HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1823239 ·
Last close
$7.60
Market Cap
$1.13B
52W High
$9.42
52W Low
$2.55
ADV30
4,059,683
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 49,866,000 | 12,842,000 | -22,529,000 | -35,681,000 | 770,577,000 | 216,890,000 | 397,866,000 |
| Sep 2025 | 41,630,000 | 5,655,000 | -33,585,000 | -25,556,000 | 849,191,000 | 243,574,000 | 417,332,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-39,518,000
Investing CF
$-12,713,000
Financing CF
$-66,825,000
CapEx
$-13,085,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.52
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$6,385,000
Inventory
$40,462,000
Receivables
$33,415,000
ST Investments
—
EBIT TTM
$-162,848,000
Pretax Income TTM
$-188,811,000
Interest Exp TTM
$25,963,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$208,775,008
EBITDA
$-19,745,000
Free Cash Flow
$-3,623,125
Enterprise Value
$1,271,875,712
Total Cash
$70,091,000
Total Debt
$218,099,008
Shares Out
148,989,545
Trailing EPS
$-0.53
Book Value
$1.37
ROE
-33.0%
ROA
-5.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 185,743,000 | -128,530,000 | -130,773,000 | 770,577,000 | 397,866,000 | 212,379,000 | -57,573,000 |
| Dec 2024 | 259,185,000 | -72,683,000 | -144,846,000 | 1,008,244,000 | 431,035,000 | 325,292,000 | 7,465,000 |
| Dec 2023 | 288,945,000 | -28,468,000 | -119,029,000 | 1,487,450,000 | 697,566,000 | 416,753,000 | 126,224,000 |
| Dec 2022 | 883,001,000 | 566,416,000 | 220,205,000 | 2,282,315,000 | 1,377,072,000 | 545,218,000 | 535,977,000 |
TTM Snapshot
Revenues TTM
$374,003,000
NetIncome TTM
$-89,012,000
OpCashFlow TTM
$0
Assets (Latest)
$770,577,000
Forward EPS
$-0.11
Max Pain — expiry 2027-03-19
max pain strike: $5.00 · spot: $7.58 · call oi: 5,727 · put oi: 138
Expected Move to 2027-03-19:
±$5.40
(71.24%) —
implied range
$2.18 –
$12.98
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPTX | Seaport Therapeutics, Inc. | $1.15B | $21.52 | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.11B | $26.13 | — |
| EVOTF | Evotec SE | $1.19B | $6.69 | — |
| MNKD | MANNKIND CORP | $1.07B | $3.34 | — |
| LBRX | LB PHARMACEUTICALS INC | $1.20B | $37.33 | — |
News headlines (Yahoo Finance, 1h cache)
Maravai LifeSciences Holdings (MRVI) Rebounded Sharply, Is The Upside Already Priced In?
2026-09-24 15:12 · Yahoo
Maravai (MRVI) Q2 2026 Earnings Call Transcript
2026-08-14 00:16 · Yahoo
Maravai LifeSciences Q2 Earnings Call Highlights
2026-08-07 05:04 · Yahoo
How The Maravai LifeSciences (MRVI) Narrative Is Shifting With New Targets And 2026 Guidance
2026-05-15 01:29 · Yahoo
Maravai (MRVI) Q1 2026 Earnings Transcript
2026-05-09 20:35 · Yahoo
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
2026-07-22 20:02 · Yahoo
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
2026-09-25 10:34 · Yahoo
Is Maravai LifeSciences Holdings (MRVI) Cheap If Cash Flow Recovers?
2026-09-25 09:09 · Yahoo
Maravai LifeSciences Holdings, Inc. Q2 2026 Earnings Call Summary
2026-08-07 12:30 · Yahoo
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
2026-08-06 21:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.